Thursday, October 31, 2024 1:44:34 PM
--Maxim Downgrades Matinas BioPharma to Hold From Buy
12:52 PM ET 10/31/24 | MT Newswires
--Maxim Downgrades Matinas BioPharma to Hold From Buy
I will hang on for a short while. HOLD, not Sell.
Expect other large company will take over MTNB
12:52 PM EDT, 10/31/2024 (MT Newswires) --
Price: 0.60, Change: -1.33, Percent Change: -68.96
12:52 PM ET 10/31/24 | MT Newswires
--Maxim Downgrades Matinas BioPharma to Hold From Buy
I will hang on for a short while. HOLD, not Sell.
Expect other large company will take over MTNB
12:52 PM EDT, 10/31/2024 (MT Newswires) --
Price: 0.60, Change: -1.33, Percent Change: -68.96
Recent MTNB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 09:01:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 09:00:36 PM
- Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards • GlobeNewswire Inc. • 04/03/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 10:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 10:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 10:15:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 09:06:14 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/25/2025 07:52:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2025 10:30:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 09:00:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/23/2025 09:14:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/23/2025 08:05:20 PM
